IL-27 maintains cytotoxic Ly6C+ γδ T cells that arise from immature precursors
-
Published:2024-05-30
Issue:14
Volume:43
Page:2878-2907
-
ISSN:1460-2075
-
Container-title:The EMBO Journal
-
language:en
-
Short-container-title:EMBO J
Author:
Wiesheu RobertORCID, Edwards Sarah C, Hedley AnnORCID, Hall HollyORCID, Tosolini MarieORCID, Fares da Silva Marcelo Gregorio Filho, Sumaria Nital, Castenmiller Suzanne M, Wardak Leyma, Optaczy YasminORCID, Lynn Amy, Hill David G, Hayes Alan J, Hay Jodie, Kilbey AnnaORCID, Shaw Robin, Whyte Declan, Walsh Peter J, Michie Alison MORCID, Graham Gerard J, Manoharan Anand, Halsey ChristinaORCID, Blyth KarenORCID, Wolkers Monika CORCID, Miller Crispin, Pennington Daniel JORCID, Jones Gareth WORCID, Fournie Jean-Jacques, Bekiaris VasileiosORCID, Coffelt Seth BORCID
Abstract
AbstractIn mice, γδ-T lymphocytes that express the co-stimulatory molecule, CD27, are committed to the IFNγ-producing lineage during thymic development. In the periphery, these cells play a critical role in host defense and anti-tumor immunity. Unlike αβ-T cells that rely on MHC-presented peptides to drive their terminal differentiation, it is unclear whether MHC-unrestricted γδ-T cells undergo further functional maturation after exiting the thymus. Here, we provide evidence of phenotypic and functional diversity within peripheral IFNγ-producing γδ T cells. We found that CD27+ Ly6C− cells convert into CD27+Ly6C+ cells, and these CD27+Ly6C+ cells control cancer progression in mice, while the CD27+Ly6C− cells cannot. The gene signatures of these two subsets were highly analogous to human immature and mature γδ-T cells, indicative of conservation across species. We show that IL-27 supports the cytotoxic phenotype and function of mouse CD27+Ly6C+ cells and human Vδ2+ cells, while IL-27 is dispensable for mouse CD27+Ly6C− cell and human Vδ1+ cell functions. These data reveal increased complexity within IFNγ-producing γδ-T cells, comprising immature and terminally differentiated subsets, that offer new insights into unconventional T-cell biology.
Funder
Breast Cancer Now Cancer Research UK Tenovus Annie McNab Bequest Little Princess Trust Wellcome Trust UKRI | Medical Research Council Versus Arthritis UKRI | Biotechnology and Biological Sciences Research Council Stichting Sanquin Bloedvoorziening
Publisher
Springer Science and Business Media LLC
Reference60 articles.
1. Baeyens A, Fang V, Chen C, Schwab SR (2015) Exit strategies: S1P signaling and T cell migration. Trends Immunol 36:778–787 2. Barros-Martins J, Schmolka N, Fontinha D, Pires de Miranda M, Simas JP, Brok I, Ferreira C, Veldhoen M, Silva-Santos B, Serre K (2016) Effector γδ T cell differentiation relies on master but not auxiliary Th cell transcription factors. J Immunol 196:3642–3652 3. Beck BH, Kim HG, Kim H, Samuel S, Liu Z, Shrestha R, Haines H, Zinn K, Lopez RD (2010) Adoptively transferred ex vivo expanded γδ T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer. Breast Cancer Res Treat 122:135–144 4. Cao G, Wang Q, Li G, Meng Z, Liu H, Tong J, Huang W, Liu Z, Jia Y, Wei J et al (2016) mTOR inhibition potentiates cytotoxicity of Vγ4 γδ T cells via up-regulating NKG2D and TNF-alpha. J Leukoc Biol 100:1181–1189 5. Chen L, He W, Kim ST, Tao J, Gao Y, Chi H, Intlekofer AM, Harvey B, Reiner SL, Yin Z et al (2007) Epigenetic and transcriptional programs lead to default IFN-γ production by γδ T cells. J Immunol 178:2730–2736
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|